Biology subjects

Pawłowski, K.

Publications and source records attributed to Pawłowski, K..

4 recordsLinked to original sources

bioRxiv2025

The NLR immune receptor Roq1 recognizes the Pseudomonas syringae HopAG1 effector via its Nudix domain

O_LIPlant nucleotide-binding leucine-rich repeat receptors (NLRs) sense directly or indirectly effectors - proteins employed by pathogens during infection. While indirect recognition can be initiated by unrelated effectors targeting the same cellular component, direct recognition is restricted by conformational constraints of the pathogen protein and corresponding receptor. C_LIO_LIRecognition of XopQ (Roq1) receptor confers resistance to bacteria expressing members of the highly conserved effector family comprising XopQ/HopQ1/RipB. The structure of the activated Roq1 was solved previously, revealing that LRR and C-JID domains of Roq1 are involved in XopQ binding. C_LIO_LIIn this study, we found that Roq1 detects HopAG1, a member of a structurally different effector family. Presence of HopAG1 in Pseudomonas syringae reduced bacterial growth and symptoms development in wild-type but not in roq1 Nicotiana benthamiana plants. Moreover, HopAG1 co-immunoprecipitated with Roq1 indicating that both proteins associate. Based on deletion and structural analyses, we postulate that this interaction occurs via the Nudix domain of HopAG1 that binds to a similar receptor interface like XopQ. C_LIO_LINudix fold is predicted in multiple pathogen effectors suggesting that Roq1 may recognize effector families other than XopQ and HopAG1. Accordingly, it is also conceivable that other TNLs may detect a broader range of effector families than supposed. C_LI

plant biology↗

bioRxiv2025

Bacterial ubiquitin ligase engineered for small molecule and protein target identification

The Legionella SidE effectors ubiquitinate host proteins independently of the canonical E1-E2 cascade. Here we engineer the SidE ligases to develop a modular proximity ligation approach for the identification of targets of small molecules and proteins, which we call SidBait. We validate the method with known small molecule-protein interactions and use it to identify CaMKII as an off-target interactor of the breast cancer drug ribociclib. Structural analysis and activity assays confirm that ribociclib binds the CaMKII active site and inhibits its activity. We further customize SidBait to identify protein-protein interactions, including substrates for enzymes, and discover the F-actin capping protein (CapZ) as a target of the Legionella effector RavB during infection. Structural and biochemical studies indicate that RavB allosterically binds CapZ and decaps actin, thus functionally mimicking eukaryotic CapZ interacting proteins. Collectively, our results establish SidBait as a reliable tool for identifying targets of small molecules and proteins.

molecular biology↗

bioRxiv2022

Proteogenomic Characterization Reveals Therapeutic Opportunities Related to Mitochondrial Function in Melanoma

The dynamics of more than 1900 mitochondrial proteins was explored through quantitative proteomics in 151 melanoma-related tissue samples of both surgical and autopsy origin. Dysregulation of mitochondrial pathways in primary tumors, metastases, and peritumoral tissues was correlated with age and survival of patients, as well as with tumor cell proliferation and the BRAF mutation status of the tumors. The outlined proteomic landscape confirmed the central role of a pathologically upregulated mitochondrial translation machinery and oxidative phosphorylation (OXPHOS) in the development, proliferation, and progression of melanomas. Our results from different melanoma cell lines confirmed our findings and we could document that treatments with selected OXPHOS inhibitors and antibiotics successfully impaired tumor cell proliferation. In addition, we provided proteomic evidence on the mechanism-of-action of the different treatments. These observations could contribute to the development of therapeutic approaches targeting the mitochondrial pathology in melanoma. TOC figure O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=134 SRC="FIGDIR/small/513481v1_ufig1.gif" ALT="Figure 1"> View larger version (58K): org.highwire.dtl.DTLVardef@11f21e2org.highwire.dtl.DTLVardef@e98c64org.highwire.dtl.DTLVardef@100145forg.highwire.dtl.DTLVardef@399284_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIMitochondrial proteome landscape outlined in 151 melanoma-related samples C_LIO_LIMitochondrial Translation and OXPHOS impact disease severity and survival C_LIO_LIBRAF V600E mutation correlates with upregulation of mitochondrial energy production C_LIO_LITargeting the mitochondrial OXPHOS and ribosomes impairs tumor cell proliferation C_LIO_LITherapeutic opportunities complementary to the standard of care are proposed C_LI In briefMitochondrial proteome profiling of melanomas reveals dysregulation in major metabolic pathways, suggesting a central role of the mitochondria within the development and progression of melanoma. Targeting mitochondrial pathways has the potential to impact the course of the disease, which provides opportunities for complementary drug interventions.

cancer biology↗

bioRxiv2020

A Legionella effector ADP-ribosyltransferase inactivates glutamate dehydrogenase

ADP-ribosyltransferases (ARTs) are a widespread superfamily of enzymes frequently employed in pathogenic strategies of bacteria. Legionella pneumophila, the causative agent of Legionnaires disease, has acquired over 330 translocated effectors that showcase remarkable biochemical and structural diversity. Here we took a bioinformatic approach to search the Legionella effector repertoire for additional divergent members of the ART superfamily and identified an ART domain in Lpg0181. We show that L. pneumophila Lpg0181 targets a specific class of 120-kDa NAD+-dependent glutamate dehydrogenase (GDH) enzymes found in fungi and protists, including many natural hosts of Legionella. Lpg0181 targets a conserved arginine residue in the NAD+ -binding pocket of GDH, thereby blocking oxidative deamination of glutamate. While intracellular pathogens employ diverse virulence mechanisms to overcome host-limited nutrient availability, Lpg0181 is--to the best of our knowledge--the first example of a Legionella effector which directly targets a host metabolic enzyme.

biochemistry↗